Average Co-Inventor Count = 7.88
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (20 from 1,535 patents)
2. Centrexion Therapeutics Corporation (5 from 36 patents)
3. Boehringer Ingelheim Pharma Gmbh & Co Kg (194 patents)
25 patents:
1. 12209094 - CCR2 receptor antagonists and uses thereof
2. 11731981 - CCR2 receptor antagonists and uses thereof
3. 11324724 - N-(2,2-difluoroethyl)-N-[(pyrimidinylamino)propanyl]arylcarboxamides
4. 11236072 - N-[(pyrimidinylamino)propanyl]-,n-[pyridylamino)propanyl]- and n-[(pyrazinylaminol)propanyl]arylcarboxamides
5. 11046706 - CCR2 receptor antagonists and uses thereof
6. 10710984 - N-[(Pyrimidinylamino)propanyl]-and N-[(Pyridinylamino)-propanyl]arylcarboxamides
7. 10196402 - CCR2 receptor antagonists and uses thereof
8. 9884854 - N-[(pyrimidinylamino)propanyl]-and N[(pyrazinylamino)proppanyl]arylcarboxamides
9. 9670222 - CCR2 receptor antagonists and uses thereof
10. 9346816 - 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
11. 9108958 - Selective CCR2 antagonists
12. 9018212 - Pyridazine carboxamides as CCR2 receptor antagonists
13. 8962656 - CCR2 antagonists
14. 8946218 - CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
15. 8877745 - CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments